← Back to Search

Chest X-ray Tomosynthesis Participants for Lung Cancer

N/A
Recruiting
Led By Albert Hsiao, MD PhD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 12/31/2026
Awards & highlights

Summary

The goal of this observational clinical trial is to learn if chest tomosynthesis is a potential alternative to computed tomography for the detection of lung cancer. It will also develop artificial intelligence tools to aid in the diagnosis of lung cancer on chest tomosynthesis images. The main questions it aims to answer are: * What is the accuracy of chest X-ray tomosynthesis in diagnosing lung cancer in a population of individuals undergoing lung cancer screening or evaluation of a suspicious lung nodule? * Can artificial intelligence help us detect lung cancer on chest tomosynthesis images? Researchers will compare chest tomosynthesis images to computed tomography scans for each participant to see how they compare in diagnosing lung cancer. Participants will a chest tomosynthesis scan in addition to their routine clinical computed tomography scan.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 12/31/2026
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 12/31/2026 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Chest X-ray tomosynthesis detection of lung cancer
Secondary study objectives
Chest X-ray tomosynthesis detection of suspicious nodules

Trial Design

1Treatment groups
Experimental Treatment
Group I: Chest X-ray Tomosynthesis ParticipantsExperimental Treatment1 Intervention
Participants who had a recent, routine clinical chest computed tomography scan for lung cancer screening or evaluation of nodule suspicious for lung cancer will undergo an additional chest X-ray tomosynthesis scan.

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,157 Previous Clinical Trials
1,570,419 Total Patients Enrolled
AIxSCAN, Inc.UNKNOWN
Albert Hsiao, MD PhDPrincipal InvestigatorUC San Diego, Department of Radiology
~667 spots leftby Dec 2026